Skip to content

Clinical Trial of Biolimus-coated Intracranial Balloon Dilation Catheter

Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Effectiveness and Safety of Biolimus-coated Intracranial Balloon Dilation Catheter Treatment of Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06140550
Enrollment
204
Registered
2023-11-20
Start date
2023-11-30
Completion date
2026-12-31
Last updated
2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Atherosclerotic Stenosis

Keywords

Intracranial balloon, stenosis

Brief summary

This test took the target lesion restenosis rate 6 months after the operation as the main endpoint to verify the effectiveness of the intracranial balloon expansion catheter of Biolimus coating. After completing the follow-up 6 months after the operation, a clinical summary report was issued for the registration application of the product, and on this basis, 12 months of postoperative follow-up was carried out to evaluate the mid-term curative effect.

Interventions

DEVICEDrug balloon dilated

Through the expansion after the balloon is in place,Release drugs on the surface of the balloon and improve the blood perfusion of nerve vessels to treat stenosis

DEVICEballoon dilated

Through the expansion after the balloon is in place, improve the blood perfusion of nerve vessels to treat stenosis.

Sponsors

Xuanwu Hospital, Beijing
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
First People's Hospital of Hangzhou
CollaboratorOTHER
Jinan Central Hospital
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Beijing Geriatric Hospital
CollaboratorOTHER
Bochang
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Ratio of control group to test group 1:1

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 80 years old; * Symptomatic intracranial artery stenosis, and the degree of visual stenosis of target blood vessels under intracranial angiography is 70\ 99%(WASID method);

Exclusion criteria

* Target blood vessels are seriously calcified and distorted, and it is difficult to put the interventional instruments in place or recover; * Ischemic cerebral infarction occurred 3 weeks before surgery; * Cerebral hemorrhage 3 months before operation;

Design outcomes

Primary

MeasureTime frame
6-month target lesion restenosis rate6-month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026